Novel Potent 5-HT1F Receptor Agonists: Structure-Activity Studies of a Series of Substituted N-[3-(1-Methyl-4-piperidinyl)-1 H-pyrrolo [3, 2-b] pyridin-5-yl] amides §

SA Filla, BM Mathes, KW Johnson…

Index: Journal of Medicinal Chemistry, , vol. 46, # 14 p. 3060 - 3071

Full Text: HTML

Citation Number: 32

Abstract

... Journal of Medicinal Chemistry. ... Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, and Synaptic Pharmaceutical Corporation, 215 College Road, Paramus, New Jersey 07652. J. Med. Chem. ...

Related Articles:

Novel Potent 5-HT1F Receptor Agonists: Structure-Activity Studies of a Series of Substituted N-[3-(1-Methyl-4-piperidinyl)-1 H-pyrrolo [3, 2-b] pyridin-5-yl] amides §

[Filla, Sandra A.; Mathes, Brian M.; Johnson, Kirk W.; Phebus, Lee A.; Cohen, Marlene L.; Nelson, David L.; Zgombick, John M.; Erickson, Jon A.; Schenck, Kathryn W.; Wainscott, David B.; Branchek, Theresa A.; Schaus, John M. Journal of Medicinal Chemistry, 2003 , vol. 46, # 14 p. 3060 - 3071]

Cell permeability as a parameter for lead generation in the protein Tyrosine kinase inhibition field

[Papageorgiou, Christos; Camenisch, Gian; Borer, Xaver Bioorganic and Medicinal Chemistry Letters, 2001 , vol. 11, # 12 p. 1549 - 1552]

Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT 1 receptors over melatonin MT 2 …

[European Journal of Medicinal Chemistry, , vol. 39, # 6 p. 515 - 526]

The serotonin 5-HT4 receptor. 2. Structure-activity studies of the indole carbazimidamide class of agonists

[Journal of medicinal chemistry, , vol. 38, # 13 p. 2331 - 2338]

More Articles...